ONPPF

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

ONCOPEPTIDES AB (ONPPF) Ownership - Who owns ONCOPEPTIDES AB?

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Vastra Tradgardsgatan 15

Phone

+46 86152040

Employees

Web

https://www.oncopeptides.com

Details

Group

Domestic Stock Funds

Fundamentals

ONPPF

Capitalization

41.8M

P/E Ratio

N/A

Risk (Beta)

-0.56

Dividend Yield

N/A

Total Cash

179M

Total Cash/Share

0.85

Total Debt

122M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.03%

Revenue

31.6M

ROE

N/A

Book Value

54.3M

P/B Ratio

10.43

Cash Flow

N/A

Earnings

-1.71

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

4.23

Current Revenue Per Employee

123925.00

Dividends Per Share - Security

N/A

EBITDA

-283.5M

Float

N/A

Float - Current

N/A

Gross Income Margin

92.67

Revenue To Assets

-117.95

Shares Held By Institutions

11.8M

Shares Outstanding - Current

211M

Total Liabilities

190M

Total Volume MTD

N/A

Value

-1

Gain YTD

0.000

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology